IM-250
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IM-250, covering 2024-10-24 to 2024-10-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers [Phase 1]